<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01917513</url>
  </required_header>
  <id_info>
    <org_study_id>G-EYE 15505</org_study_id>
    <nct_id>NCT01917513</nct_id>
  </id_info>
  <brief_title>Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy</brief_title>
  <official_title>Prospective Randomized Trial to Compare the Clinical Efficiency (Adenoma Detection Rate) of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smart Medical Systems Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smart Medical Systems Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the adenoma detection rate of G-EYE™ high definition
      colonoscopy with that of standard high definition colonoscopy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multicenter, two-arm, randomized, open-label study intended to compare the
      detection rate obtained by performing G-EYE™ high definition colonoscopy vs. the detection
      rate obtained by performing high definition standard colonoscopy.

      The study will enroll 1000 subjects. Consecutive adult subjects who were referred for
      elective colonoscopy will be asked to enroll into this randomized clinical study if the
      candidate meets the study inclusion and exclusion criteria.

      Subjects will sign informed consent form and undergo randomization. The study includes a
      run-in preliminary phase of 270 patients to allow physicians to get familiar with the G-EYE™
      endoscope.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2014</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Detection Rate of Adenomas and Serrated Lesions</measure>
    <time_frame>Approximalty following 14 days (histology results)</time_frame>
    <description>The percentage of patients with at least one adenoma or serrated lesion in the G-EYE™ group will be compared to the Standard group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Polyp and Adenoma Detection, Procedure Times and Safety (Number of Patients With Adverse Events.</measure>
    <time_frame>Up to 14 days (histology results)</time_frame>
    <description>The secondary outcome is a composite-each of the measured parameters will be reported as a single value for each arm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1000</enrollment>
  <condition>Adenoma</condition>
  <condition>Polyps</condition>
  <condition>Colorectal Cancer</condition>
  <arm_group>
    <arm_group_label>G-EYE™ colonoscopy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>G-EYE™ colonoscopy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Colonoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard Colonoscopy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>G-EYE™ colonoscopy</intervention_name>
    <description>G-EYE™ colonoscopy</description>
    <arm_group_label>G-EYE™ colonoscopy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Standard Colonoscopy</intervention_name>
    <description>Standard Colonoscopy</description>
    <arm_group_label>Standard Colonoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients over 50 years old

          2. Referred to colonoscopy for screening, following positive FOBT testing, change of
             bowel habits or for surveillance colonoscopy (history of adenoma resection).

          3. The patient must understand and provide written consent for the procedure.

        Exclusion Criteria:

          1. Subjects with inflammatory bowel disease;

          2. Subjects with a personal history of polyposis syndrome;

          3. Subjects with suspected chronic stricture potentially precluding complete colonoscopy;

          4. Subjects with diverticulitis or toxic megacolon;

          5. Subjects with a history of radiation therapy to abdomen or pelvis;

          6. Pregnant or lactating female subjects;

          7. Subjects who are currently enrolled in another clinical investigation.

          8. Subjects with current oral or parenteral use of anticoagulants

          9. Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)

         10. Any patient condition deemed too risky for the study by the investigator

         11. Previous colonic surgery (except for appendectomy)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralf Kiesslich, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center, Harvard Medical School</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herlev Hospital</name>
      <address>
        <city>Harlev</city>
        <zip>2730</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin Johannes Gutenberg University Mainz</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Tübingen</name>
      <address>
        <city>Tübingen</city>
        <zip>D-72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Dr. Horst Schmidt Kliniken (HSK)</name>
      <address>
        <city>Wiesbaden</city>
        <zip>65199</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asian Institute of Gastroenterology</name>
      <address>
        <city>Hyderabad</city>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hadassah Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91999</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Laniado Hospital</name>
      <address>
        <city>Netanya</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Assaf Harofeh Medical Center</name>
      <address>
        <city>Tzrifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vita Salute San Raffaele University - Scientific Institute San Raffaele</name>
      <address>
        <city>Milan</city>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Centre</name>
      <address>
        <city>Maastricht</city>
        <zip>6202AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radboud UMC</name>
      <address>
        <city>Nijmegen</city>
        <zip>6500 HB</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham City University</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Russells Hall Hospital</name>
      <address>
        <city>Dudley</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
    <country>Germany</country>
    <country>India</country>
    <country>Israel</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>France</country>
    <country>Poland</country>
    <country>Spain</country>
    <country>Turkey</country>
  </removed_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 30, 2013</study_first_submitted>
  <study_first_submitted_qc>August 4, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2013</study_first_posted>
  <results_first_submitted>December 18, 2017</results_first_submitted>
  <results_first_submitted_qc>December 26, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">January 23, 2018</results_first_posted>
  <last_update_submitted>December 26, 2017</last_update_submitted>
  <last_update_submitted_qc>December 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Adenoma</keyword>
  <keyword>Polyps</keyword>
  <keyword>CRC</keyword>
  <keyword>Colonoscopy</keyword>
  <keyword>Detection Yield</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Adenoma</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Standard Colonoscopy</title>
          <description>Patients in this group underwent standard high definition colonoscopy</description>
        </group>
        <group group_id="P2">
          <title>G-EYE™ Colonoscopy</title>
          <description>Patients in this group underwent G-EYE™ high definition colonoscopy using using an insufflated balloon during withdrawal</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="502"/>
                <participants group_id="P2" count="498"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="407"/>
                <participants group_id="P2" count="396"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="95"/>
                <participants group_id="P2" count="102"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Standard Colonoscopy</title>
          <description>Patients in this group underwent standard high definition colonoscopy</description>
        </group>
        <group group_id="B2">
          <title>G-EYE™ Colonoscopy</title>
          <description>Patients in this group underwent G-EYE™ high definition colonoscopy using using an insufflated balloon during withdrawal</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="396"/>
            <count group_id="B2" value="407"/>
            <count group_id="B3" value="803"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.2" spread="8.79"/>
                    <measurement group_id="B2" value="65.4" spread="8.92"/>
                    <measurement group_id="B3" value="65.3" spread="8.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="173"/>
                    <measurement group_id="B2" value="204"/>
                    <measurement group_id="B3" value="377"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="223"/>
                    <measurement group_id="B2" value="203"/>
                    <measurement group_id="B3" value="426"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Detection Rate of Adenomas and Serrated Lesions</title>
        <description>The percentage of patients with at least one adenoma or serrated lesion in the G-EYE™ group will be compared to the Standard group</description>
        <time_frame>Approximalty following 14 days (histology results)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Standard Colonoscopy</title>
            <description>Patients in this group underwent standard high definition colonoscopy</description>
          </group>
          <group group_id="O2">
            <title>G-EYE™ Colonoscopy</title>
            <description>Patients in this group underwent G-EYE™ high definition colonoscopy using using an insufflated balloon during withdrawal</description>
          </group>
        </group_list>
        <measure>
          <title>Detection Rate of Adenomas and Serrated Lesions</title>
          <description>The percentage of patients with at least one adenoma or serrated lesion in the G-EYE™ group will be compared to the Standard group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="392"/>
                <count group_id="O2" value="404"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="147"/>
                    <measurement group_id="O2" value="194"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Polyp and Adenoma Detection, Procedure Times and Safety (Number of Patients With Adverse Events.</title>
        <description>The secondary outcome is a composite-each of the measured parameters will be reported as a single value for each arm</description>
        <time_frame>Up to 14 days (histology results)</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>G-EYE™ Colonoscopy</title>
          <description>G-EYE™ colonoscopy
G-EYE™ colonoscopy: G-EYE™ colonoscopy</description>
        </group>
        <group group_id="E2">
          <title>Standard Colonoscopy</title>
          <description>Standard Colonoscopy
Standard Colonoscopy: Standard Colonoscopy</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="502"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>an irregular heart rate and bradycardia prior to the initiation of the procedure</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="502"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="498"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>obstructive sigmoid tumor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="502"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="498"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="502"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="498"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Prof. Ralf Kiesslich</name_or_title>
      <organization>Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany</organization>
      <email>ralf.kiesslich@hsk-wiesbaden.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

